# reload+after+2024-01-23 19:44:09.091710
address1§Am Strande 7
city§Rostock
zip§18055
country§Germany
phone§49 381 80113 500
fax§49 381 8011 3401
website§https://www.centogene.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
fullTimeEmployees§444
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Kim  Stratton', 'age': 61, 'title': 'CEO & Member of Management Board', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 943312, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jose Miguel Coego Rios', 'title': 'CFO, Legal & IT and Member of Management Board', 'fiscalYear': 2022, 'totalPay': 327584, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Peter  Bauer M.D.', 'age': 53, 'title': 'Chief Medical & Genomic Officer and Member of Management Board', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 188443, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrin  Oswald M.D., Ph.D.', 'age': 51, 'title': 'Advisor', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 954268, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ian  Rentsch', 'title': 'Chief Commercial Officer & GM of Pharma', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§6
compensationRisk§7
shareHolderRightsRisk§5
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.728
priceToSalesTrailing12Months§0.65944153
currency§USD
dateShortInterest§1702598400
forwardEps§-1.06
exchange§NGM
quoteType§EQUITY
shortName§Centogene N.V.
longName§Centogene N.V.
firstTradeDateEpochUtc§1573137000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§8e44662b-97f3-3f3a-929a-62e91e68c91c
gmtOffSetMilliseconds§-18000000
targetHighPrice§1.5
targetLowPrice§1.5
targetMeanPrice§1.5
targetMedianPrice§1.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§1.192
grossMargins§0.40353
ebitdaMargins§-0.65266
trailingPegRatio§None
